Reproductive System Flashcards
Estrogen receptor agonist
Ethinylestradiol
Estrogen receptor agonist and antagonist (SERM)
Tamoxifen,Raloxifene, clomiphene
Estrogen receptor antagonist
Fulvestrant
Aromatase inhibitors
Anastrozole
Synthetic progesterone analogue (progestins)
Medroxyprogesterone,Levonorgestrel,Dydrogesterone
Antiprogestins
Mifepristone
Estrogen effects
Endometrial and mammary gland proliferation (increase tumor risk),inhibits osteoclast activity, increase blood coagulation,promote water and electrolyte retention, decrease glucose tolerance,affect blood lipid level, increase bile lithogenicity
Progestins effects
Inhibit endometrial proliferaiphase and stimulate mammary gland proliferation (increase tumor risk),promote use of adipose tissue for energy metabolism, increase blood coagulation some prevent water retention,impair glucose tolerance,affect blood lipid level,do not affect bile lithogenicity
Both estrogen and progesterone are bad for
DM, hypercholesterolemia, obesity patients due decrease glucose tolerance,increase lipid content in blood
Both progesterone and estrogen provide feedback inhibion on
Release of FSH/LH secretion in adenohypophysis.also have effect on hypothalamic release of GnRH
Combination oral contraceptive (both estrogen and progesterone) fn
Change cervix environment,altered transportation of egg,sperm and fertilizer ovum, unfavorable endometrial environment
Estrogen and progesterone receptors are seen in
All organs mainly ovary,uterus,vagina,bones,breast, hypothalamus, pituitary gland, blood vessels
Estrogen receptors are
ER alpha and beta
Progesterone receptors are
PR-a and B
Both estrogen and progesterone receptors are
Nuclear receptors
Estrogen and progesterone cause
Estrogen and progesterone regulated gene transcription
Testesterone,5alpha dihydrotestosterone (DHT) receptor
Intranuclear Androgen receptor (ARs)
Symptoms of menopause
Hot flushes,nausea, headache, tachycardia,sweating , palpitations,night sweats
Increase in Gn RH and gonadotropin during menopause is due to
Decrease in feedback inhibition by estrogen
Symptoms of menopause are caused due to
Activation of thermoregulatory centers of hypothalamus by gonadotropin which is uncontrolled
Hormone replacement therapy can be done to
Reduce symptoms of menopause
Women with hysterectomy may use
Estrogen therapy
Women with preserved uterus can use
Combined estrogen and progesterone HRT
Combined therapy for uterus preserved women helps to reduce
Risk of endometrial Cancer
Hypogonadism treatment
HRT
Primary hypogonadism cause
Growth and puberty delay,which cause dysfunction of hypothalamus, pituitary gland and some genetic disorders
Secondary hypogonadism is caused by
Chronic diseases like tumor, hyperprolactinemia that affects GnRH secretion,also some medication,dooungs and radiation
Endometriosis
Endometrial implantation outside uterus cause severe pelvic pain
Endometriosis treatment
Hormonal therapy with progestins or GnRH agonists or surgery if necessary
Hormonal therapy with progestins will
Reduce the proliferation of endometrium and it also shrinks the endometrium ,which is good for endometriosis
GnRH agonists
First increase the amount of FSH and LH ,but then downregultes it in continuous use
Combined oral contraceptive eg
Levonorgestrel (contain both estrogen and progesterone
Targets of COC
Hypothalamus, pituitary gland, endometrium,ovary, cervix
COC fn
Inhibit both FSH and LH release and thereby prevent follicle maturation eliminate preovulatory LH wave and suppressed ovulation
Progestins additional fn
Affect cervical secretion,inhibits endometrial proliferation,inhibits ovarian and uterine peristalsis
COC indication
Endometriosis,acne, dysmenorrhoea, premenstrual syndrome
Dysmenorrhoea
Painful menstrual cramps
Premenstrual syndrome
Emotional,physical and behavioural changes 1 or 2 weeks before menstruation
Single phase COC
Fixed dose of estrogen and progesterone throughout the cycle
Progestins high dose
Completely inhibits follicle dev and ovulation,changes cervical mucus properties And cause endometrial changes
Intermediate dose of progestin
Inhibit ovulation,but doesn’t affect follicle dev
Low dose progestin cause
Doesn’t completely inhibits ovulation and give intrauterine contraceptive effect
POC full form
Progestin only regular oral contraceptive
POC is better contraceptive for women with
Cardiovascular disease and risk of dev of thrombosis,age over 35,smokers,lactating women,women with migraine type headache
POC (Progestin )effect
Thisckend cervical wall,inhibits endometrial proliferation, reduce tubal and uterine peristalsis
Emergency contraception is
High dose of progestins taken over next 72 hour after intercourse
Ethinylestradiol effect
Replace endogenous hormone,increase bone mineral density, estrogen replacement ,inhibits follicular maturation and ovulation, Hormonal suppressive effect
Clinical use of estrogen
Estrogen replacement therapy in menopause and postmenopause, hypogonadism
Ethinylestradiol has more bioavailability than
Estradiol
Estradiol is widely used in
Topical pharmaceutical formulation
Side effects of ethinylestradiol
Deep vein thrombosis,risk of dev of endometrial or breast cancer
Estrogen has positive effect on
Breast,endometrium and bone tissue
Only SERM that has positive effect on breast tissue
Estrogens
Tamoxifen has positive effect ion
Endometrium and bone ,but negative effects on breast tissue
Raloxifene has positive effect Only on
Bone tissue,it has negative effects on endometrium and breast
In estrogen and SERM ,positive effect on endometrium is given by
Estrogen and tamoxifen
In estrogen and SERM , positive effect on bone tissue are done by
Estrogen, tamoxifen and Raloxifene
Difference in tissue sensitivity to SERM is caused by
Difference in localisation of receptor, effect of transcriptional cofactors on receptor (coactivators and corepressors)
Dominant cofactor determine
Agonist or antagonist effect on SERM
Tamoxifen is
ER antagonist in breast tissue and partial agonist in endometrium and bone
Tamoxifen do not stimulate
DNA synthesis, but inhibit cell division causing regression of malignant cells(Antiproliferative)
Tamoxifen indication
Breast cancer
Tamoxifen SE
Deep vein thrombosis, endometrial hyperplasia
Raloxifene action
Partial ER agonist in bone tissue,ER antagonist in endometrium and breast tissue (anti resorptive effect), Decrease LDL
Indication of raloxifene
Osteoporosis prevention and therapy
SE of raloxifene
Deep vein thrombosis
Clomiphene
ER antagonist in hypothalamus and adenohypophysis, partial ER agonist in ovaries, stimulate release of FSH and LH(blocks negative feedback), stimulate formation and maturation of ovarian follicle and ovulation
Indication of clomiphene
Anovulatory cycle, ovulation stimulation
SE of clomiphene
Overstimulation of ovaries
Fulvestrant (ER antagonist in all tissue) action
Inhibit intracellular dimerization and binding of ER to ER element and downregultes ER density (Antiproliferative)
Fulvestrant indication
Breast cancer
Androstenedione produced from adipose tissue (cholesterol) is converted to estrone by
Aromatase in post menopause,which is further converted to estradiol
Anastrozole (aromatase inhibitor) action
Decrease estrogen synthesis ,so Antiproliferative
Indication of anastrozole
Breast cancer in menopause
SE of anastrozole
Decrease bone mineral density
Medroxyprogesterone (progesterone receptor agonist) action
Inhibit proliferation phase, thickens cervical mucus,interfer with tubal and uterine peristalsis -so hormone suppressive effect
Medroxyprogesterone use
Progestin contraception, endometriosis
SE of medroxyprogesterone
Impaired menstrual bleeding, decrease bone density due to its antiestrogenic effect and glucocorticoid activity of it,that inhibit osteoblast
Levonorgestrel (progesterone receptors agonists) action
Inhibit proliferation phase, thickens cervical mucus,impairs peristalsis in tubule and uterus -hormone suppressive effect , inhibits ovulation
Indication of Levonorgestrel
COC,POC
In Levonorgestrel used in IUD
Ovulation is not inhibited, contraceptive effect only in uterus
Levonorgestrel used as Emergency contraception,basic mechanism is
Inhibition of ovulation, rather than POC mechanism
Dydrogesterone (progestin receptor agonist) action
In uterus forms endometrial secretory phase in estrogen filled uterus,provide protection against elevated estrogen induced endometrial hyperplasia
Dydrogesterone has no contraceptive effect
On therapeutic dose
Dydrogesterone inhibits
Estrogen receptor synthesis in endometrium
Indication of Dydrogesterone
Conditions caused by endogenous progesterone deficiency like dysmenorrhoea, endometriosis, impending abortion ,… Hormonal replacement therapy
All progesterone receptors agonists have
Antiestrogenic effect
Levonorgestrel and medroxyprogesterone has
Androgen action
Antiandrogenic action is given by
Cyproterone only
Levonorgestrel and medroxyprogesterone has both
Antiestrogenic action and Androgen action
Cyproterone has both
Antiestrogenic action and antiandrogenic action
Levonorgestrel is not recommended for
Women with hyperandrogenism
Antiandrogenic effect of progestins helps against
Acne vulgaris (cyproterone)
Mifepristone (progesterone receptors antagonist) action
It is is also glucocorticoid receptor antagonist,blocks progesterone effect on endometrium, stimulate prostaglandin release and thereby cause myometrium contractions
Mifepristone use
Termination of pregnancy in first trimester,hypercortisolism(in high dose)
Mifepristone SE
Severe vaginal bleeding
LH stimulate release of testesterone from
Leydig cells
In prostate cells testesterone is converted to 5 alpha dihydrotestosterone by the enzyme
5 alpha reductase
5alpha dihydrotestosterone (DHT) has
10 fold more affinity to receptor than testesterone
Testesterone is converted to estrogen in peripheral tissue by
Aromatase
Aromatase also control LH secretion by
Negative feedback along with androgens
Effects of testesterone
Stimulate spermatogenesis, promote erythropoiesis, increase skeletal muscle mass and strength,maintain bone mineral density
Androgen receptor agonists
Testesterone and nandrolone
Androgen receptor antagonist
Flutamide
Androgen receptor antagonist and Progestin receptor agonist
Cyproterone
5 Alpha reductase inhibitor
Finasteride
Benign prostate hyperplasia
Benign Stromal and epithelial cell hyperplasia in periurethral area of prostate,cause urinary tract disorder, conservative therapy used
Hyperandrogenism/polycystic ovarian syndrome
Elevated levels of male hormones in women
PCOS risks and symptoms
Miscarriage, pregnancy complications, Hirsutism, acne,adipositate
Testesterone action
Androgenic action in prostate and testicles , protein anabolic action in muscle,bone, hematopoiesis,liver)
Testesterone has
First pass effect
Use of testesterone
Hypogonadism
Nandrolone (Androgen receptor agonists) has
Enhanced anabolic effect and reduce androgenic effect ,is a testesterone derivative
Andrew action
Stimulate erythropoietin secretion,increase BOne mineral density, promote protein synthesis, stimulate carbohydrate and lipid metabolism
Nandrolone used a d
Doping drug -prohibited
Use of nandrolone
Refractory anemia, osteoporosis (not used in women due to virilizing effect)
High doses of anabolic steroids may cause secondary cause of hypogonadism and infertility due to
Inhibition of gonadotropin secretion, testesterone formation and spermatogenesis
Prostate cells without Androgen will undergo
Apoptosis
Androgen receptor antagonist are of 2 types
Non steroidalor pure anti androgens like flutamide
Steroidal anti Androgen like cyproterone
Steroidal anti Androgen also have properties of
Progestin
Flutamide action (anti Androgen non steroidal)
Antiproliferative
Use of Flutamide
Prostate cancer (together with GnRH receptor agonists)
SE flutamide
May increase LH secretion due to feedback mechanism
Cyproterone (steroidal Androgen receptor antagonist and Progestin receptor agonist ) action
Inhibition of Androgen activity in target tissue, action of Progestin receptor agonist inhibits LH secretion through feedback,inhibits testesterone synthesis - so Antiproliferative and anti gonadotropic effect
Use of cyproterone
Prostate cancer, Hirsutism and severe acne in women(hyperandrogenisity)
Contraindications of cyproterone
Pregnancy
Finasteride (5 alpha reductase inhibitor) action
Prevent conversation of testesterone to DHT,triggers prostate epithelial cell apoptosis,so decrease prostate size and urination disorders, it has both antiandrogenic and Antiproliferative effect
Use of finasteride
Benign prostate adenoma or hyperplasia,androgenic alopecia, Hirsutism in women
SE of finasteride
Decrease in libido and erectile dysfunction
Contraindications of finasteride
Pregnant women or women who is going to be pregnant
While using transdermal testesterone gel(androgel) should be advised to avoid
Skin to skin contact with pregnant women
While prescribing Androgen to male patients advice that
Cholestatic hepatitis and jaundice may occur with low doses of Androgen
Sildenafil use
Primary hypertension and erectile dysfunction
Women with migraine are not advised to use estrogen because
Increased risk of stroke
Medroxyprogesterone injection has SE
Depression
Sildenafil (Viagra)SE
Dev of chest pain or dizziness
Raloxifene a ta on estrogen receptor in
Bone ,endometrium
Interactions of sildenafil with nitrates cause
Fatal hypotension
Androgens are used for
Symptomatic treatment of male deficiency,female libido, endometriosis, postmenopausal symptoms, increased muscle mass
Estrogen effects
Main bone density by increasing bone reabsorption, maintain normal structure of skin and blood vessels
Progesterone inhibits endometrial proliferation phase.True or false
False
Pheromones are examples of
Ectohormone